Germline Testing in Prostate Cancer: Implementation and Disparities of Care

Affiliations

¹ Levine Cancer Institute, Atrium Health, Charlotte, NC.
² Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC.

Editorial

Landon C Brown et al. JCO Oncol Pract. 2023 May.

. 2023 May;19(5):221-223.

doi: 10.1200/OP.22.00804. Epub 2023 Jan 31.

¹ Levine Cancer Institute, Atrium Health, Charlotte, NC.
² Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC.

No abstract available

Comment on

Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer.
Kwon DH, Gordon KM, Tong B, Borno HT, Beigh M, Fattah D, Schleicher A, Aggarwal RR, Blanco AM, Small EJ, Dhawan M. Kwon DH, et al. JCO Oncol Pract. 2023 May;19(5):e773-e783. doi: 10.1200/OP.22.00638. Epub 2023 Jan 12. JCO Oncol Pract. 2023. PMID: 36649492
Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review.
Briggs LG, Steele GL, Qian ZJ, Subbana S, Alkhatib KY, Labban M, Langbein BJ, Nguyen DD, Cellini J, Kilbridge K, Kibel AS, Trinh QD, Rana HQ, Cole AP. Briggs LG, et al. JCO Oncol Pract. 2023 May;19(5):e784-e793. doi: 10.1200/OP.22.00634. Epub 2023 Jan 12. JCO Oncol Pract. 2023. PMID: 36649495